| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5642145 | Journal of Oral and Maxillofacial Surgery | 2017 | 9 Pages |
Abstract
The results of the present study support evidence that the pEGFR signaling pathway might be implicated in the malignant transformation of mobile tongue SCC. Additional studies are recommended to validate whether pEGFR could be used as a potential biomarker and therapeutic target in mobile tongue SCC.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Stamatios MD, PhD, Constantinos MSc, PhD, Eugene BSc, MSc, Irene MD, PhD, Jose MD, PhD, Efstratios MD, PhD, Jerzy MD, PhD,